Global Nuclide Drugs Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our (LP Info Research) latest study, the global Nuclide Drugs market size was valued at US$ million in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Nuclide Drugs is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global Nuclide Drugs market. With recovery from influence of COVID-19 and the Russia-Ukraine War, Nuclide Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Nuclide Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Nuclide Drugs market.
Key Features:
The report on Nuclide Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Nuclide Drugs market. It may include historical data, market segmentation by Type (e.g., Technetium-99, Iodine-123), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Nuclide Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Nuclide Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Nuclide Drugs industry. This include advancements in Nuclide Drugs technology, Nuclide Drugs new entrants, Nuclide Drugs new investment, and other innovations that are shaping the future of Nuclide Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Nuclide Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for Nuclide Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Nuclide Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Nuclide Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Nuclide Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Nuclide Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Nuclide Drugs market.
Market Segmentation:
Nuclide Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our (LP Info Research) latest study, the global Nuclide Drugs market size was valued at US$ million in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Nuclide Drugs is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global Nuclide Drugs market. With recovery from influence of COVID-19 and the Russia-Ukraine War, Nuclide Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Nuclide Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Nuclide Drugs market.
Key Features:
The report on Nuclide Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Nuclide Drugs market. It may include historical data, market segmentation by Type (e.g., Technetium-99, Iodine-123), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Nuclide Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Nuclide Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Nuclide Drugs industry. This include advancements in Nuclide Drugs technology, Nuclide Drugs new entrants, Nuclide Drugs new investment, and other innovations that are shaping the future of Nuclide Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Nuclide Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for Nuclide Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Nuclide Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Nuclide Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Nuclide Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Nuclide Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Nuclide Drugs market.
Market Segmentation:
Nuclide Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Technetium-99
- Iodine-123
- Iodine-125
- Iodine-131
- Fluorine-18
- Gallium-67
- Others
- Therapeutic Use
- Diagnostic Use
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GE Healthcare
- Cardinal Health
- Curium Pharma
- Lantheus Medical Imaging, Inc.
- Eczac?baє? Monrol Nuclear Products
- Novartis International AG
- Siemens
- China Isotope & Radiation
- Yantai Dongcheng Pharmaceutical
- Jubilant Life Sciences
- Bracco
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nuclide Drugs Market Size 2018-2029
2.1.2 Nuclide Drugs Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Nuclide Drugs Segment by Type
2.2.1 Technetium-99
2.2.2 Iodine-123
2.2.3 Iodine-125
2.2.4 Iodine-131
2.2.5 Fluorine-18
2.2.6 Gallium-67
2.2.7 Others
2.3 Nuclide Drugs Market Size by Type
2.3.1 Nuclide Drugs Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Nuclide Drugs Market Size Market Share by Type (2018-2023)
2.4 Nuclide Drugs Segment by Application
2.4.1 Therapeutic Use
2.4.2 Diagnostic Use
2.5 Nuclide Drugs Market Size by Application
2.5.1 Nuclide Drugs Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Nuclide Drugs Market Size Market Share by Application (2018-2023)
3 NUCLIDE DRUGS MARKET SIZE BY PLAYER
3.1 Nuclide Drugs Market Size Market Share by Players
3.1.1 Global Nuclide Drugs Revenue by Players (2018-2023)
3.1.2 Global Nuclide Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Nuclide Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NUCLIDE DRUGS BY REGIONS
4.1 Nuclide Drugs Market Size by Regions (2018-2023)
4.2 Americas Nuclide Drugs Market Size Growth (2018-2023)
4.3 APAC Nuclide Drugs Market Size Growth (2018-2023)
4.4 Europe Nuclide Drugs Market Size Growth (2018-2023)
4.5 Middle East & Africa Nuclide Drugs Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Nuclide Drugs Market Size by Country (2018-2023)
5.2 Americas Nuclide Drugs Market Size by Type (2018-2023)
5.3 Americas Nuclide Drugs Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nuclide Drugs Market Size by Region (2018-2023)
6.2 APAC Nuclide Drugs Market Size by Type (2018-2023)
6.3 APAC Nuclide Drugs Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nuclide Drugs by Country (2018-2023)
7.2 Europe Nuclide Drugs Market Size by Type (2018-2023)
7.3 Europe Nuclide Drugs Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nuclide Drugs by Region (2018-2023)
8.2 Middle East & Africa Nuclide Drugs Market Size by Type (2018-2023)
8.3 Middle East & Africa Nuclide Drugs Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NUCLIDE DRUGS MARKET FORECAST
10.1 Global Nuclide Drugs Forecast by Regions (2024-2029)
10.1.1 Global Nuclide Drugs Forecast by Regions (2024-2029)
10.1.2 Americas Nuclide Drugs Forecast
10.1.3 APAC Nuclide Drugs Forecast
10.1.4 Europe Nuclide Drugs Forecast
10.1.5 Middle East & Africa Nuclide Drugs Forecast
10.2 Americas Nuclide Drugs Forecast by Country (2024-2029)
10.2.1 United States Nuclide Drugs Market Forecast
10.2.2 Canada Nuclide Drugs Market Forecast
10.2.3 Mexico Nuclide Drugs Market Forecast
10.2.4 Brazil Nuclide Drugs Market Forecast
10.3 APAC Nuclide Drugs Forecast by Region (2024-2029)
10.3.1 China Nuclide Drugs Market Forecast
10.3.2 Japan Nuclide Drugs Market Forecast
10.3.3 Korea Nuclide Drugs Market Forecast
10.3.4 Southeast Asia Nuclide Drugs Market Forecast
10.3.5 India Nuclide Drugs Market Forecast
10.3.6 Australia Nuclide Drugs Market Forecast
10.4 Europe Nuclide Drugs Forecast by Country (2024-2029)
10.4.1 Germany Nuclide Drugs Market Forecast
10.4.2 France Nuclide Drugs Market Forecast
10.4.3 UK Nuclide Drugs Market Forecast
10.4.4 Italy Nuclide Drugs Market Forecast
10.4.5 Russia Nuclide Drugs Market Forecast
10.5 Middle East & Africa Nuclide Drugs Forecast by Region (2024-2029)
10.5.1 Egypt Nuclide Drugs Market Forecast
10.5.2 South Africa Nuclide Drugs Market Forecast
10.5.3 Israel Nuclide Drugs Market Forecast
10.5.4 Turkey Nuclide Drugs Market Forecast
10.5.5 GCC Countries Nuclide Drugs Market Forecast
10.6 Global Nuclide Drugs Forecast by Type (2024-2029)
10.7 Global Nuclide Drugs Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 GE Healthcare
11.1.1 GE Healthcare Company Information
11.1.2 GE Healthcare Nuclide Drugs Product Offered
11.1.3 GE Healthcare Nuclide Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 GE Healthcare Main Business Overview
11.1.5 GE Healthcare Latest Developments
11.2 Cardinal Health
11.2.1 Cardinal Health Company Information
11.2.2 Cardinal Health Nuclide Drugs Product Offered
11.2.3 Cardinal Health Nuclide Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Cardinal Health Main Business Overview
11.2.5 Cardinal Health Latest Developments
11.3 Curium Pharma
11.3.1 Curium Pharma Company Information
11.3.2 Curium Pharma Nuclide Drugs Product Offered
11.3.3 Curium Pharma Nuclide Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Curium Pharma Main Business Overview
11.3.5 Curium Pharma Latest Developments
11.4 Lantheus Medical Imaging, Inc.
11.4.1 Lantheus Medical Imaging, Inc. Company Information
11.4.2 Lantheus Medical Imaging, Inc. Nuclide Drugs Product Offered
11.4.3 Lantheus Medical Imaging, Inc. Nuclide Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Lantheus Medical Imaging, Inc. Main Business Overview
11.4.5 Lantheus Medical Imaging, Inc. Latest Developments
11.5 Eczac?baє? Monrol Nuclear Products
11.5.1 Eczac?baє? Monrol Nuclear Products Company Information
11.5.2 Eczac?baє? Monrol Nuclear Products Nuclide Drugs Product Offered
11.5.3 Eczac?baє? Monrol Nuclear Products Nuclide Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Eczac?baє? Monrol Nuclear Products Main Business Overview
11.5.5 Eczac?baє? Monrol Nuclear Products Latest Developments
11.6 Novartis International AG
11.6.1 Novartis International AG Company Information
11.6.2 Novartis International AG Nuclide Drugs Product Offered
11.6.3 Novartis International AG Nuclide Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Novartis International AG Main Business Overview
11.6.5 Novartis International AG Latest Developments
11.7 Siemens
11.7.1 Siemens Company Information
11.7.2 Siemens Nuclide Drugs Product Offered
11.7.3 Siemens Nuclide Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Siemens Main Business Overview
11.7.5 Siemens Latest Developments
11.8 China Isotope & Radiation
11.8.1 China Isotope & Radiation Company Information
11.8.2 China Isotope & Radiation Nuclide Drugs Product Offered
11.8.3 China Isotope & Radiation Nuclide Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 China Isotope & Radiation Main Business Overview
11.8.5 China Isotope & Radiation Latest Developments
11.9 Yantai Dongcheng Pharmaceutical
11.9.1 Yantai Dongcheng Pharmaceutical Company Information
11.9.2 Yantai Dongcheng Pharmaceutical Nuclide Drugs Product Offered
11.9.3 Yantai Dongcheng Pharmaceutical Nuclide Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Yantai Dongcheng Pharmaceutical Main Business Overview
11.9.5 Yantai Dongcheng Pharmaceutical Latest Developments
11.10 Jubilant Life Sciences
11.10.1 Jubilant Life Sciences Company Information
11.10.2 Jubilant Life Sciences Nuclide Drugs Product Offered
11.10.3 Jubilant Life Sciences Nuclide Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Jubilant Life Sciences Main Business Overview
11.10.5 Jubilant Life Sciences Latest Developments
11.11 Bracco
11.11.1 Bracco Company Information
11.11.2 Bracco Nuclide Drugs Product Offered
11.11.3 Bracco Nuclide Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Bracco Main Business Overview
11.11.5 Bracco Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nuclide Drugs Market Size 2018-2029
2.1.2 Nuclide Drugs Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Nuclide Drugs Segment by Type
2.2.1 Technetium-99
2.2.2 Iodine-123
2.2.3 Iodine-125
2.2.4 Iodine-131
2.2.5 Fluorine-18
2.2.6 Gallium-67
2.2.7 Others
2.3 Nuclide Drugs Market Size by Type
2.3.1 Nuclide Drugs Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Nuclide Drugs Market Size Market Share by Type (2018-2023)
2.4 Nuclide Drugs Segment by Application
2.4.1 Therapeutic Use
2.4.2 Diagnostic Use
2.5 Nuclide Drugs Market Size by Application
2.5.1 Nuclide Drugs Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Nuclide Drugs Market Size Market Share by Application (2018-2023)
3 NUCLIDE DRUGS MARKET SIZE BY PLAYER
3.1 Nuclide Drugs Market Size Market Share by Players
3.1.1 Global Nuclide Drugs Revenue by Players (2018-2023)
3.1.2 Global Nuclide Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Nuclide Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NUCLIDE DRUGS BY REGIONS
4.1 Nuclide Drugs Market Size by Regions (2018-2023)
4.2 Americas Nuclide Drugs Market Size Growth (2018-2023)
4.3 APAC Nuclide Drugs Market Size Growth (2018-2023)
4.4 Europe Nuclide Drugs Market Size Growth (2018-2023)
4.5 Middle East & Africa Nuclide Drugs Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Nuclide Drugs Market Size by Country (2018-2023)
5.2 Americas Nuclide Drugs Market Size by Type (2018-2023)
5.3 Americas Nuclide Drugs Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nuclide Drugs Market Size by Region (2018-2023)
6.2 APAC Nuclide Drugs Market Size by Type (2018-2023)
6.3 APAC Nuclide Drugs Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nuclide Drugs by Country (2018-2023)
7.2 Europe Nuclide Drugs Market Size by Type (2018-2023)
7.3 Europe Nuclide Drugs Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nuclide Drugs by Region (2018-2023)
8.2 Middle East & Africa Nuclide Drugs Market Size by Type (2018-2023)
8.3 Middle East & Africa Nuclide Drugs Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NUCLIDE DRUGS MARKET FORECAST
10.1 Global Nuclide Drugs Forecast by Regions (2024-2029)
10.1.1 Global Nuclide Drugs Forecast by Regions (2024-2029)
10.1.2 Americas Nuclide Drugs Forecast
10.1.3 APAC Nuclide Drugs Forecast
10.1.4 Europe Nuclide Drugs Forecast
10.1.5 Middle East & Africa Nuclide Drugs Forecast
10.2 Americas Nuclide Drugs Forecast by Country (2024-2029)
10.2.1 United States Nuclide Drugs Market Forecast
10.2.2 Canada Nuclide Drugs Market Forecast
10.2.3 Mexico Nuclide Drugs Market Forecast
10.2.4 Brazil Nuclide Drugs Market Forecast
10.3 APAC Nuclide Drugs Forecast by Region (2024-2029)
10.3.1 China Nuclide Drugs Market Forecast
10.3.2 Japan Nuclide Drugs Market Forecast
10.3.3 Korea Nuclide Drugs Market Forecast
10.3.4 Southeast Asia Nuclide Drugs Market Forecast
10.3.5 India Nuclide Drugs Market Forecast
10.3.6 Australia Nuclide Drugs Market Forecast
10.4 Europe Nuclide Drugs Forecast by Country (2024-2029)
10.4.1 Germany Nuclide Drugs Market Forecast
10.4.2 France Nuclide Drugs Market Forecast
10.4.3 UK Nuclide Drugs Market Forecast
10.4.4 Italy Nuclide Drugs Market Forecast
10.4.5 Russia Nuclide Drugs Market Forecast
10.5 Middle East & Africa Nuclide Drugs Forecast by Region (2024-2029)
10.5.1 Egypt Nuclide Drugs Market Forecast
10.5.2 South Africa Nuclide Drugs Market Forecast
10.5.3 Israel Nuclide Drugs Market Forecast
10.5.4 Turkey Nuclide Drugs Market Forecast
10.5.5 GCC Countries Nuclide Drugs Market Forecast
10.6 Global Nuclide Drugs Forecast by Type (2024-2029)
10.7 Global Nuclide Drugs Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 GE Healthcare
11.1.1 GE Healthcare Company Information
11.1.2 GE Healthcare Nuclide Drugs Product Offered
11.1.3 GE Healthcare Nuclide Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 GE Healthcare Main Business Overview
11.1.5 GE Healthcare Latest Developments
11.2 Cardinal Health
11.2.1 Cardinal Health Company Information
11.2.2 Cardinal Health Nuclide Drugs Product Offered
11.2.3 Cardinal Health Nuclide Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Cardinal Health Main Business Overview
11.2.5 Cardinal Health Latest Developments
11.3 Curium Pharma
11.3.1 Curium Pharma Company Information
11.3.2 Curium Pharma Nuclide Drugs Product Offered
11.3.3 Curium Pharma Nuclide Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Curium Pharma Main Business Overview
11.3.5 Curium Pharma Latest Developments
11.4 Lantheus Medical Imaging, Inc.
11.4.1 Lantheus Medical Imaging, Inc. Company Information
11.4.2 Lantheus Medical Imaging, Inc. Nuclide Drugs Product Offered
11.4.3 Lantheus Medical Imaging, Inc. Nuclide Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Lantheus Medical Imaging, Inc. Main Business Overview
11.4.5 Lantheus Medical Imaging, Inc. Latest Developments
11.5 Eczac?baє? Monrol Nuclear Products
11.5.1 Eczac?baє? Monrol Nuclear Products Company Information
11.5.2 Eczac?baє? Monrol Nuclear Products Nuclide Drugs Product Offered
11.5.3 Eczac?baє? Monrol Nuclear Products Nuclide Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Eczac?baє? Monrol Nuclear Products Main Business Overview
11.5.5 Eczac?baє? Monrol Nuclear Products Latest Developments
11.6 Novartis International AG
11.6.1 Novartis International AG Company Information
11.6.2 Novartis International AG Nuclide Drugs Product Offered
11.6.3 Novartis International AG Nuclide Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Novartis International AG Main Business Overview
11.6.5 Novartis International AG Latest Developments
11.7 Siemens
11.7.1 Siemens Company Information
11.7.2 Siemens Nuclide Drugs Product Offered
11.7.3 Siemens Nuclide Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Siemens Main Business Overview
11.7.5 Siemens Latest Developments
11.8 China Isotope & Radiation
11.8.1 China Isotope & Radiation Company Information
11.8.2 China Isotope & Radiation Nuclide Drugs Product Offered
11.8.3 China Isotope & Radiation Nuclide Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 China Isotope & Radiation Main Business Overview
11.8.5 China Isotope & Radiation Latest Developments
11.9 Yantai Dongcheng Pharmaceutical
11.9.1 Yantai Dongcheng Pharmaceutical Company Information
11.9.2 Yantai Dongcheng Pharmaceutical Nuclide Drugs Product Offered
11.9.3 Yantai Dongcheng Pharmaceutical Nuclide Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Yantai Dongcheng Pharmaceutical Main Business Overview
11.9.5 Yantai Dongcheng Pharmaceutical Latest Developments
11.10 Jubilant Life Sciences
11.10.1 Jubilant Life Sciences Company Information
11.10.2 Jubilant Life Sciences Nuclide Drugs Product Offered
11.10.3 Jubilant Life Sciences Nuclide Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Jubilant Life Sciences Main Business Overview
11.10.5 Jubilant Life Sciences Latest Developments
11.11 Bracco
11.11.1 Bracco Company Information
11.11.2 Bracco Nuclide Drugs Product Offered
11.11.3 Bracco Nuclide Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Bracco Main Business Overview
11.11.5 Bracco Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nuclide Drugs Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Technetium-99
Table 3. Major Players of Iodine-123
Table 4. Major Players of Iodine-125
Table 5. Major Players of Iodine-131
Table 6. Major Players of Fluorine-18
Table 7. Major Players of Gallium-67
Table 8. Major Players of Others
Table 9. Nuclide Drugs Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Nuclide Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 11. Global Nuclide Drugs Market Size Market Share by Type (2018-2023)
Table 12. Nuclide Drugs Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 13. Global Nuclide Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 14. Global Nuclide Drugs Market Size Market Share by Application (2018-2023)
Table 15. Global Nuclide Drugs Revenue by Players (2018-2023) & ($ Millions)
Table 16. Global Nuclide Drugs Revenue Market Share by Player (2018-2023)
Table 17. Nuclide Drugs Key Players Head office and Products Offered
Table 18. Nuclide Drugs Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Nuclide Drugs Market Size by Regions 2018-2023 & ($ Millions)
Table 22. Global Nuclide Drugs Market Size Market Share by Regions (2018-2023)
Table 23. Global Nuclide Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 24. Global Nuclide Drugs Revenue Market Share by Country/Region (2018-2023)
Table 25. Americas Nuclide Drugs Market Size by Country (2018-2023) & ($ Millions)
Table 26. Americas Nuclide Drugs Market Size Market Share by Country (2018-2023)
Table 27. Americas Nuclide Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 28. Americas Nuclide Drugs Market Size Market Share by Type (2018-2023)
Table 29. Americas Nuclide Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 30. Americas Nuclide Drugs Market Size Market Share by Application (2018-2023)
Table 31. APAC Nuclide Drugs Market Size by Region (2018-2023) & ($ Millions)
Table 32. APAC Nuclide Drugs Market Size Market Share by Region (2018-2023)
Table 33. APAC Nuclide Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 34. APAC Nuclide Drugs Market Size Market Share by Type (2018-2023)
Table 35. APAC Nuclide Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 36. APAC Nuclide Drugs Market Size Market Share by Application (2018-2023)
Table 37. Europe Nuclide Drugs Market Size by Country (2018-2023) & ($ Millions)
Table 38. Europe Nuclide Drugs Market Size Market Share by Country (2018-2023)
Table 39. Europe Nuclide Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 40. Europe Nuclide Drugs Market Size Market Share by Type (2018-2023)
Table 41. Europe Nuclide Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 42. Europe Nuclide Drugs Market Size Market Share by Application (2018-2023)
Table 43. Middle East & Africa Nuclide Drugs Market Size by Region (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Nuclide Drugs Market Size Market Share by Region (2018-2023)
Table 45. Middle East & Africa Nuclide Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Nuclide Drugs Market Size Market Share by Type (2018-2023)
Table 47. Middle East & Africa Nuclide Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 48. Middle East & Africa Nuclide Drugs Market Size Market Share by Application (2018-2023)
Table 49. Key Market Drivers & Growth Opportunities of Nuclide Drugs
Table 50. Key Market Challenges & Risks of Nuclide Drugs
Table 51. Key Industry Trends of Nuclide Drugs
Table 52. Global Nuclide Drugs Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 53. Global Nuclide Drugs Market Size Market Share Forecast by Regions (2024-2029)
Table 54. Global Nuclide Drugs Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 55. Global Nuclide Drugs Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 56. GE Healthcare Details, Company Type, Nuclide Drugs Area Served and Its Competitors
Table 57. GE Healthcare Nuclide Drugs Product Offered
Table 58. GE Healthcare Nuclide Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 59. GE Healthcare Main Business
Table 60. GE Healthcare Latest Developments
Table 61. Cardinal Health Details, Company Type, Nuclide Drugs Area Served and Its Competitors
Table 62. Cardinal Health Nuclide Drugs Product Offered
Table 63. Cardinal Health Main Business
Table 64. Cardinal Health Nuclide Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Cardinal Health Latest Developments
Table 66. Curium Pharma Details, Company Type, Nuclide Drugs Area Served and Its Competitors
Table 67. Curium Pharma Nuclide Drugs Product Offered
Table 68. Curium Pharma Main Business
Table 69. Curium Pharma Nuclide Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Curium Pharma Latest Developments
Table 71. Lantheus Medical Imaging, Inc. Details, Company Type, Nuclide Drugs Area Served and Its Competitors
Table 72. Lantheus Medical Imaging, Inc. Nuclide Drugs Product Offered
Table 73. Lantheus Medical Imaging, Inc. Main Business
Table 74. Lantheus Medical Imaging, Inc. Nuclide Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Lantheus Medical Imaging, Inc. Latest Developments
Table 76. Eczac?baє? Monrol Nuclear Products Details, Company Type, Nuclide Drugs Area Served and Its Competitors
Table 77. Eczac?baє? Monrol Nuclear Products Nuclide Drugs Product Offered
Table 78. Eczac?baє? Monrol Nuclear Products Main Business
Table 79. Eczac?baє? Monrol Nuclear Products Nuclide Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Eczac?baє? Monrol Nuclear Products Latest Developments
Table 81. Novartis International AG Details, Company Type, Nuclide Drugs Area Served and Its Competitors
Table 82. Novartis International AG Nuclide Drugs Product Offered
Table 83. Novartis International AG Main Business
Table 84. Novartis International AG Nuclide Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Novartis International AG Latest Developments
Table 86. Siemens Details, Company Type, Nuclide Drugs Area Served and Its Competitors
Table 87. Siemens Nuclide Drugs Product Offered
Table 88. Siemens Main Business
Table 89. Siemens Nuclide Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Siemens Latest Developments
Table 91. China Isotope & Radiation Details, Company Type, Nuclide Drugs Area Served and Its Competitors
Table 92. China Isotope & Radiation Nuclide Drugs Product Offered
Table 93. China Isotope & Radiation Main Business
Table 94. China Isotope & Radiation Nuclide Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. China Isotope & Radiation Latest Developments
Table 96. Yantai Dongcheng Pharmaceutical Details, Company Type, Nuclide Drugs Area Served and Its Competitors
Table 97. Yantai Dongcheng Pharmaceutical Nuclide Drugs Product Offered
Table 98. Yantai Dongcheng Pharmaceutical Main Business
Table 99. Yantai Dongcheng Pharmaceutical Nuclide Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Yantai Dongcheng Pharmaceutical Latest Developments
Table 101. Jubilant Life Sciences Details, Company Type, Nuclide Drugs Area Served and Its Competitors
Table 102. Jubilant Life Sciences Nuclide Drugs Product Offered
Table 103. Jubilant Life Sciences Main Business
Table 104. Jubilant Life Sciences Nuclide Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Jubilant Life Sciences Latest Developments
Table 106. Bracco Details, Company Type, Nuclide Drugs Area Served and Its Competitors
Table 107. Bracco Nuclide Drugs Product Offered
Table 108. Bracco Nuclide Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 109. Bracco Main Business
Table 110. Bracco Latest Developments
Table 1. Nuclide Drugs Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Technetium-99
Table 3. Major Players of Iodine-123
Table 4. Major Players of Iodine-125
Table 5. Major Players of Iodine-131
Table 6. Major Players of Fluorine-18
Table 7. Major Players of Gallium-67
Table 8. Major Players of Others
Table 9. Nuclide Drugs Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Nuclide Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 11. Global Nuclide Drugs Market Size Market Share by Type (2018-2023)
Table 12. Nuclide Drugs Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 13. Global Nuclide Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 14. Global Nuclide Drugs Market Size Market Share by Application (2018-2023)
Table 15. Global Nuclide Drugs Revenue by Players (2018-2023) & ($ Millions)
Table 16. Global Nuclide Drugs Revenue Market Share by Player (2018-2023)
Table 17. Nuclide Drugs Key Players Head office and Products Offered
Table 18. Nuclide Drugs Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Nuclide Drugs Market Size by Regions 2018-2023 & ($ Millions)
Table 22. Global Nuclide Drugs Market Size Market Share by Regions (2018-2023)
Table 23. Global Nuclide Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 24. Global Nuclide Drugs Revenue Market Share by Country/Region (2018-2023)
Table 25. Americas Nuclide Drugs Market Size by Country (2018-2023) & ($ Millions)
Table 26. Americas Nuclide Drugs Market Size Market Share by Country (2018-2023)
Table 27. Americas Nuclide Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 28. Americas Nuclide Drugs Market Size Market Share by Type (2018-2023)
Table 29. Americas Nuclide Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 30. Americas Nuclide Drugs Market Size Market Share by Application (2018-2023)
Table 31. APAC Nuclide Drugs Market Size by Region (2018-2023) & ($ Millions)
Table 32. APAC Nuclide Drugs Market Size Market Share by Region (2018-2023)
Table 33. APAC Nuclide Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 34. APAC Nuclide Drugs Market Size Market Share by Type (2018-2023)
Table 35. APAC Nuclide Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 36. APAC Nuclide Drugs Market Size Market Share by Application (2018-2023)
Table 37. Europe Nuclide Drugs Market Size by Country (2018-2023) & ($ Millions)
Table 38. Europe Nuclide Drugs Market Size Market Share by Country (2018-2023)
Table 39. Europe Nuclide Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 40. Europe Nuclide Drugs Market Size Market Share by Type (2018-2023)
Table 41. Europe Nuclide Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 42. Europe Nuclide Drugs Market Size Market Share by Application (2018-2023)
Table 43. Middle East & Africa Nuclide Drugs Market Size by Region (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Nuclide Drugs Market Size Market Share by Region (2018-2023)
Table 45. Middle East & Africa Nuclide Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Nuclide Drugs Market Size Market Share by Type (2018-2023)
Table 47. Middle East & Africa Nuclide Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 48. Middle East & Africa Nuclide Drugs Market Size Market Share by Application (2018-2023)
Table 49. Key Market Drivers & Growth Opportunities of Nuclide Drugs
Table 50. Key Market Challenges & Risks of Nuclide Drugs
Table 51. Key Industry Trends of Nuclide Drugs
Table 52. Global Nuclide Drugs Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 53. Global Nuclide Drugs Market Size Market Share Forecast by Regions (2024-2029)
Table 54. Global Nuclide Drugs Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 55. Global Nuclide Drugs Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 56. GE Healthcare Details, Company Type, Nuclide Drugs Area Served and Its Competitors
Table 57. GE Healthcare Nuclide Drugs Product Offered
Table 58. GE Healthcare Nuclide Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 59. GE Healthcare Main Business
Table 60. GE Healthcare Latest Developments
Table 61. Cardinal Health Details, Company Type, Nuclide Drugs Area Served and Its Competitors
Table 62. Cardinal Health Nuclide Drugs Product Offered
Table 63. Cardinal Health Main Business
Table 64. Cardinal Health Nuclide Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Cardinal Health Latest Developments
Table 66. Curium Pharma Details, Company Type, Nuclide Drugs Area Served and Its Competitors
Table 67. Curium Pharma Nuclide Drugs Product Offered
Table 68. Curium Pharma Main Business
Table 69. Curium Pharma Nuclide Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Curium Pharma Latest Developments
Table 71. Lantheus Medical Imaging, Inc. Details, Company Type, Nuclide Drugs Area Served and Its Competitors
Table 72. Lantheus Medical Imaging, Inc. Nuclide Drugs Product Offered
Table 73. Lantheus Medical Imaging, Inc. Main Business
Table 74. Lantheus Medical Imaging, Inc. Nuclide Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Lantheus Medical Imaging, Inc. Latest Developments
Table 76. Eczac?baє? Monrol Nuclear Products Details, Company Type, Nuclide Drugs Area Served and Its Competitors
Table 77. Eczac?baє? Monrol Nuclear Products Nuclide Drugs Product Offered
Table 78. Eczac?baє? Monrol Nuclear Products Main Business
Table 79. Eczac?baє? Monrol Nuclear Products Nuclide Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Eczac?baє? Monrol Nuclear Products Latest Developments
Table 81. Novartis International AG Details, Company Type, Nuclide Drugs Area Served and Its Competitors
Table 82. Novartis International AG Nuclide Drugs Product Offered
Table 83. Novartis International AG Main Business
Table 84. Novartis International AG Nuclide Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Novartis International AG Latest Developments
Table 86. Siemens Details, Company Type, Nuclide Drugs Area Served and Its Competitors
Table 87. Siemens Nuclide Drugs Product Offered
Table 88. Siemens Main Business
Table 89. Siemens Nuclide Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Siemens Latest Developments
Table 91. China Isotope & Radiation Details, Company Type, Nuclide Drugs Area Served and Its Competitors
Table 92. China Isotope & Radiation Nuclide Drugs Product Offered
Table 93. China Isotope & Radiation Main Business
Table 94. China Isotope & Radiation Nuclide Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. China Isotope & Radiation Latest Developments
Table 96. Yantai Dongcheng Pharmaceutical Details, Company Type, Nuclide Drugs Area Served and Its Competitors
Table 97. Yantai Dongcheng Pharmaceutical Nuclide Drugs Product Offered
Table 98. Yantai Dongcheng Pharmaceutical Main Business
Table 99. Yantai Dongcheng Pharmaceutical Nuclide Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Yantai Dongcheng Pharmaceutical Latest Developments
Table 101. Jubilant Life Sciences Details, Company Type, Nuclide Drugs Area Served and Its Competitors
Table 102. Jubilant Life Sciences Nuclide Drugs Product Offered
Table 103. Jubilant Life Sciences Main Business
Table 104. Jubilant Life Sciences Nuclide Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Jubilant Life Sciences Latest Developments
Table 106. Bracco Details, Company Type, Nuclide Drugs Area Served and Its Competitors
Table 107. Bracco Nuclide Drugs Product Offered
Table 108. Bracco Nuclide Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 109. Bracco Main Business
Table 110. Bracco Latest Developments
LIST OF FIGURES
Figure 1. Nuclide Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nuclide Drugs Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Nuclide Drugs Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Nuclide Drugs Sales Market Share by Country/Region (2022)
Figure 8. Nuclide Drugs Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Nuclide Drugs Market Size Market Share by Type in 2022
Figure 10. Nuclide Drugs in Therapeutic Use
Figure 11. Global Nuclide Drugs Market: Therapeutic Use (2018-2023) & ($ Millions)
Figure 12. Nuclide Drugs in Diagnostic Use
Figure 13. Global Nuclide Drugs Market: Diagnostic Use (2018-2023) & ($ Millions)
Figure 14. Global Nuclide Drugs Market Size Market Share by Application in 2022
Figure 15. Global Nuclide Drugs Revenue Market Share by Player in 2022
Figure 16. Global Nuclide Drugs Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Nuclide Drugs Market Size 2018-2023 ($ Millions)
Figure 18. APAC Nuclide Drugs Market Size 2018-2023 ($ Millions)
Figure 19. Europe Nuclide Drugs Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Nuclide Drugs Market Size 2018-2023 ($ Millions)
Figure 21. Americas Nuclide Drugs Value Market Share by Country in 2022
Figure 22. United States Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Nuclide Drugs Market Size Market Share by Region in 2022
Figure 27. APAC Nuclide Drugs Market Size Market Share by Type in 2022
Figure 28. APAC Nuclide Drugs Market Size Market Share by Application in 2022
Figure 29. China Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Nuclide Drugs Market Size Market Share by Country in 2022
Figure 36. Europe Nuclide Drugs Market Size Market Share by Type (2018-2023)
Figure 37. Europe Nuclide Drugs Market Size Market Share by Application (2018-2023)
Figure 38. Germany Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Nuclide Drugs Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Nuclide Drugs Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Nuclide Drugs Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 52. APAC Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 53. Europe Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 55. United States Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 56. Canada Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 59. China Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 60. Japan Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 61. Korea Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 63. India Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 64. Australia Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 65. Germany Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 66. France Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 67. UK Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 68. Italy Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 69. Russia Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 70. Spain Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 73. Israel Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 76. Global Nuclide Drugs Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Nuclide Drugs Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Nuclide Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nuclide Drugs Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Nuclide Drugs Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Nuclide Drugs Sales Market Share by Country/Region (2022)
Figure 8. Nuclide Drugs Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Nuclide Drugs Market Size Market Share by Type in 2022
Figure 10. Nuclide Drugs in Therapeutic Use
Figure 11. Global Nuclide Drugs Market: Therapeutic Use (2018-2023) & ($ Millions)
Figure 12. Nuclide Drugs in Diagnostic Use
Figure 13. Global Nuclide Drugs Market: Diagnostic Use (2018-2023) & ($ Millions)
Figure 14. Global Nuclide Drugs Market Size Market Share by Application in 2022
Figure 15. Global Nuclide Drugs Revenue Market Share by Player in 2022
Figure 16. Global Nuclide Drugs Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Nuclide Drugs Market Size 2018-2023 ($ Millions)
Figure 18. APAC Nuclide Drugs Market Size 2018-2023 ($ Millions)
Figure 19. Europe Nuclide Drugs Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Nuclide Drugs Market Size 2018-2023 ($ Millions)
Figure 21. Americas Nuclide Drugs Value Market Share by Country in 2022
Figure 22. United States Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Nuclide Drugs Market Size Market Share by Region in 2022
Figure 27. APAC Nuclide Drugs Market Size Market Share by Type in 2022
Figure 28. APAC Nuclide Drugs Market Size Market Share by Application in 2022
Figure 29. China Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Nuclide Drugs Market Size Market Share by Country in 2022
Figure 36. Europe Nuclide Drugs Market Size Market Share by Type (2018-2023)
Figure 37. Europe Nuclide Drugs Market Size Market Share by Application (2018-2023)
Figure 38. Germany Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Nuclide Drugs Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Nuclide Drugs Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Nuclide Drugs Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Nuclide Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 52. APAC Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 53. Europe Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 55. United States Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 56. Canada Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 59. China Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 60. Japan Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 61. Korea Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 63. India Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 64. Australia Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 65. Germany Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 66. France Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 67. UK Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 68. Italy Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 69. Russia Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 70. Spain Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 73. Israel Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Nuclide Drugs Market Size 2024-2029 ($ Millions)
Figure 76. Global Nuclide Drugs Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Nuclide Drugs Market Size Market Share Forecast by Application (2024-2029)
